Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 1

Interventions

Cisplatin 508Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 328Paclitaxel 324Oxaliplatin 323Gemcitabine 320Docetaxel 310Fluorouracil 282Drug Therapy 243apatinib 242Bevacizumab 228camrelizumab 214Etoposide 200Irinotecan 175Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138Pemetrexed 136Cytarabine 136anlotinib 135toripalimab 130Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 116Radiosurgery 116

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Interventional × 89Zr-bevacizumab × Clear all
NCT01859234 2013-05-21

89Zr-bevacizumab PET Scan in Patients With Relapsing Multiple Myeloma

University Medical Center Groningen

Phase NA Unknown
20 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡